Argen X Stock Quote ARGX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

604.60

Bid

587.00

Ask

610.00

Volume

169,990

586.40 Day's Range 606.40

271.00 52 Week Range 613.00

Market Cap

35.789B

Previous Close

599.80

Open

597.80

Last Trade

100

604.6

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

58,304

Shares Outstanding

59,194,000

Dividend Yield

PE Ratio

-121.30

Earnings Per Share (EPS)

-4.98

Revenue

1.27B

Net Profit

-295.05M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.argenx.com

Headquarters

Amsterdam, North Holland, Nld

Founded

Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 599.80 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 613.00 €.

Argen X currently has 59,194,000 shares outstanding. The market capitalization of Argen X is 35.50 € billion. Argen X has a price to earnings ratio (PE ratio) of -121.30.

argenx to Present at Upcoming Investor Conferences

November 26, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for...

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx...

argenx to Participate at Upcoming Investor Conferences

November 5, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

$573 million in third quarter global net product sales CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Management to host conference...

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

October 24, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability...

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced...

argenx to Present at Upcoming Investor Conferences

August 28, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

$478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	23.6	4.06196213425	581	613	577.4	62076	599.54503963	DE
4	33.6	5.88441330998	571	613	569.6	61368	589.97939387	DE
12	129.9	27.3646513588	474.7	613	467.6	58304	546.24457958	DE
26	251.4	71.1778029445	353.2	613	352.9	63420	488.46246358	DE
52	321.6	113.639575972	283	613	271	62234	420.51209553	DE
156	285.4	89.4110275689	319.2	613	224.1	65339	376.08755572	DE
260	455.1	304.414715719	149.5	613	93.05	74489	297.94845287	DE

ARGX - Frequently Asked Questions (FAQ)

What is the current Argen X share price?

The current share price of Argen X is 604.60 €

How many Argen X shares are in issue?

Argen X has 59,194,000 shares in issue

What is the market cap of Argen X?

The market capitalisation of Argen X is EUR 35.5B

What is the 1 year trading range for Argen X share price?

Argen X has traded in the range of 271.00 € to 613.00 € during the past year

What is the PE ratio of Argen X?

The price to earnings ratio of Argen X is -121.3

What is the cash to sales ratio of Argen X?

The cash to sales ratio of Argen X is 28.21

What is the reporting currency for Argen X?

Argen X reports financial results in USD

What is the latest annual turnover for Argen X?

The latest annual turnover of Argen X is USD 1.27B

What is the latest annual profit for Argen X?

The latest annual profit of Argen X is USD -295.05M

What is the registered address of Argen X?

The registered address for Argen X is LAARDERHOOGTWEG 25, AMSTERDAM, NORTH HOLLAND, 1101 EB

What is the Argen X website address?

The website address for Argen X is www.argenx.com

Which industry sector does Argen X operate in?

Argen X operates in the COML PHYSICAL, BIOLOGCL RESH sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TMBSZTME Pharma NV	0.02 € (185.71%)	132.5k
MLGEQGentlemen S Equity SA	0.0175 € (118.75%)	1.14k
ALCYBCybergun	0.0002 € (100.00%)	17.54M
MLAAHAmatheon Agri Holding NV	0.0185 € (54.17%)	40.1k
ALARFAdeunis	0.94 € (28.77%)	5.27k
MLSMLSmalto	0.0125 € (-37.50%)	2.34k
MLFTIFrance Tourisme Immobilier	0.025 € (-35.90%)	56.77k
CNVCnova NV	0.209 € (-19.62%)	26.38k
MLWEAWeaccess Group	0.382 € (-16.96%)	5.95k
ALEUPEuroplasma	0.0353 € (-15.95%)	3.16M
ATOAtos SE	0.0021 € (0.00%)	2.71B
BCPBanco Comercial Portugues SA	0.4493 € (-0.69%)	66.54M
ALHGLouis Hachette Group	1.3342 € (4.87%)	52.04M
KPNKoninklijke KPN NV	3.509 € (-1.21%)	26.9M
VIVVivendi SE	2.51 € (2.41%)	26.39M